MEDICA : Cell Medica Gets Orphan Drug Designation in European Union for ... 4-traders (press release) Cytovir ADV is based upon a new paradigm for the treatment of infections in patients following bone marrow transplantation. Derived from T-cells which provide immunity to the virus in the bone marrow donor, Cytovir ADV is being investigated as a novel ... |
